Fluoroquinolones Resistance Among Canine Uropathogenic Escherichia coli Strains
WSAVA 2002 Congress
*Constança Pomba-Féria, Marta Costa, Mónica Ferreira, José Duarte Correia, Manuela Caniça
*CIISA, Faculty of Veterinary Medicine, Rua Prof. Cid dos Santos
Lisbon, PT
cferia@fmv.utl.pt

OBJECTIVES

To evaluate in vitro efficacy of enrofloxacin, marbofloxacin and ciprofloxacin against Escherichia coli strains isolated from dogs with urinary tract infection.

MATERIALS

A total of 75 E. coli strains were isolated from urine specimens collected from dogs with urinary tract infection. Significant bacteriuria criteria used in this study were as follows: for cystocentesis samples - >102 CFU/ml; for catheter samples - >103 or 104 CFU/ml; for midstream urine - >105 CFU/ml. Clinical manifestations and pyuria quantitation (>5 leucocytes/400 power field) were also taken in consideration in the above criteria. Strains were biotyped using the API 20E system. Minimal Inhibitory Concentrations (MIC) were done by broth microdilution with enrofloxacin (ENR), marbofloxacin (MAR) and ciprofloxacin (CIP), according to NCCLS guidelines.

RESULTS

Cumulative MIC values analysis demonstrated that MIC50 values were 0,031 ug/ml for CIP and 0,062 ug/ml for both MAR and ENR. However, MAR and CIP resistance was detected in 9 out of 75 strains (12%), and ENR resistance occurred in 10 out of 75 strains (13,3%). The level of resistance detected implied MIC90 values of 16 ug/ml for the three fluoroquinolones studied. Since resistance breakpoint established for these three quinolones is > or equal than 2 ug/ml, MIC90 values of CIP, MAR and ENR showed a relevant level of resistance against uropathogenic E. coli strains.

CONCLUSION

We found an emerging level of resistance towards fluoroquinolones in canine E. coli strains isolated from urinary tract infection. This work shows the importance of antibiotic pressure in therapy and the need for antimicrobial resistance surveillance in veterinary medicine.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Constança Pomba-Féria
CIISA, Faculty of Veterinary Medicine
Rua Prof. Cid dos Santos
Lisbon, Lisbon 1300-477 PT

José Duarte Correia
CIISA, Faculty of Veterinary Medicine

Manuela Caniça
Antibiotic Resistance Unit, NIH Dr. Ricardo Jorge

Marta Costa
CIISA, Faculty of Veterinary Medicine and Laboratórios Atral-Cipan

Mónica Ferreira
Antibiotic Resistance Unit, NIH Dr. Ricardo Jorge


MAIN : : Fluoroquinolones Resistance
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27